All INCY Content

Incyte Corporation (INCY) Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology (AAD) Annual Meeting

Incyte Corporation (NASDAQ: INCY) FY 2026 Other Release

March 20, 20261 min read

Incyte Corporation (INCY) Q4 2025 Earnings Call Transcript

Incyte Corporation (NASDAQ: INCY) Q4 2025 Earnings Call dated Feb. 10, 2026 Corporate Participants: Alexis Smith — Vice President &...

March 10, 202649 min read

Incyte Corporation (INCY) Sec Form 8K

Incyte Corporation (NASDAQ: INCY) Sec Form 8K

March 7, 20261 min read

Incyte Corporation (INCY) Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)

Incyte Corporation (NASDAQ: INCY) FY 2026 Other Release

March 6, 20261 min read

Incyte Corporation (INCY) Barclays 28th Annual Global Healthcare Conference

Incyte Corporation (NASDAQ: INCY) FY 2026 Corporate Conference

February 17, 20261 min read

Incyte Corporation (INCY) Leerink Partners 2026 Global Healthcare Conference

Incyte Corporation (NASDAQ: INCY) FY 2026 Corporate Conference

February 17, 20261 min read

Incyte Corporation (INCY) TD Cowen 46th Annual Health Care Conference

Incyte Corporation (NASDAQ: INCY) FY 2026 Corporate Conference

February 17, 20261 min read

Incyte Corporation (INCY) Sec Form 10K

Incyte Corporation (NASDAQ: INCY) Sec Form 10K

February 11, 20261 min read

Incyte Corporation (INCY) Sec Form 8K

Incyte Corporation (NASDAQ: INCY) Sec Form 8K

February 11, 20261 min read

Earnings Previews

Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance

Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year increase driven by demand for...

February 10, 20264 min read